Slingshot members are tracking this event:

The results of the REVEAL study of Anacetrapib (MK-0859) in LDL-C lowering will be presented at the European Society of Cardiology meeting on Aug. 29, 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
MRK Community voting in process
Slingshot Insights Explained
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Ldl-c, Anacetrapib, Mk-0859